Defender Capital, Llc. Age X Therapeutics, Inc. Transaction History

Defender Capital, Llc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$0.57 - $1.0 $19,431 - $34,090	-34,090 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$0.65 - $1.2 $440 - $812	-677 Reduced 1.95%	34,090 $29,000
Q4 2021 Feb 01, 2022	SELL	$0.53 - $1.09 $68 - $141	-130 Reduced 0.37%	34,767 $38,000
Q1 2021 Apr 20, 2021	SELL	$1.56 - $2.7 $2,340 - $4,050	-1,500 Reduced 4.12%	34,897 $57,000
Q4 2020 Jan 25, 2021	BUY	$0.8 - $2.56 $640 - $2,048	800 Added 2.25%	36,397 $55,000
Q3 2020 Oct 23, 2020	SELL	$0.79 - $1.52 $5,925 - $11,400	-7,500 Reduced 17.4%	35,597 $29,000
Q2 2020 Jul 10, 2020	SELL	$0.68 - $1.13 $5,372 - $8,927	-7,900 Reduced 15.49%	43,097 $41,000
Q1 2020 May 14, 2020	SELL	$0.78 - $1.95 $68,012 - $170,030	-87,195 Reduced 63.1%	50,997 $47,000
Q4 2019 Feb 03, 2020	SELL	$1.25 - $1.82 $83,662 - $121,812	-66,930 Reduced 32.63%	138,192 $251,000
Q3 2019 Oct 17, 2019	SELL	$1.96 - $3.38 $113,141 - $195,110	-57,725 Reduced 21.96%	205,122 $407,000
Q2 2019 Aug 20, 2019	SELL	$2.58 - $4.92 $142,354 - $271,465	-55,176 Reduced 17.35%	262,847 $938,000
Q1 2019 Apr 23, 2019	SELL	$3.0 - $4.85 $86,346 - $139,592	-28,782 Reduced 8.3%	318,023 $1.32 Million
Q4 2018 Feb 08, 2019	BUY	$2.49 - $5.5 $863,544 - $1.91 Million	346,805 New	346,805 $1.38 Million

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Defender Capital, Llc., based on Form 13F filings with the SEC.

Stay updated on Defender Capital, Llc. with notifications on news.